Skip to main content
Menu
Revvity logo
Contact us

Loading...

US
Search all

Loading...

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Login/Register here
Revvity web shop online account

Get exclusive pricing on all online purchases.

Login to your Revvity.com account for your account's pricing, easy re-ordering from favorites & order history, priority order processing, and dynamic order tracking.

Login Register
Revvity Omics portal accounts

Initiate a new order or access test status and results for clinical genomics or newborn screening services.

View login options
Breadcrumb
...
  • Home
  • Blog
  • Disease Research
  • Definitive evidence of narcolepsy as an autoimmune disease.
definitive-blog

Blog

Disease Research

May 13th 2024

1 min read

Definitive evidence of narcolepsy as an autoimmune disease.

Help us improve your Revvity blog experience!

Feedback

Narcolepsy is a chronic neurological disorder in which the brain’s ability to regulate the sleep-wake cycle is disrupted. The most obvious symptom of narcolepsy is excessive daytime sleepiness (EDS) regardless of the amount of sleep the individual gets at night. All persons with narcolepsy exhibit EDS. Other symptoms can include sudden cataplexy when the person is awake, paralysis and hallucinations on the edges of sleep, and insomnia during regular night-time sleep hours.

Research suggests that narcolepsy is caused by autoimmune activity that targets hypocretin (HCRT)–producing neurons in the hypothalamus. Hypocretins are neuropeptides that play a role in the sleep-wake cycle, acting primarily as excitatory neurotransmitters.

The attribution of narcolepsy to autoimmunity has thus far been based on its strong association with HLA-DQB1*06:02 and immune dysregulation, as well as to observations of incidences of narcolepsy related to influenza and vaccines. However, definitive evidence of autoreactive immune cells had not previously been identified.  

Recently, Dr. Daniela Latorre at ETH Zurich led a team of researchers and neurologists in an investigation of T cell involvement in narcolepsy patients. Their research focused on assessing the presence and state of autoreactive CD4+ and CD8+ T cells directed against HCRT neuronal antigens in the blood and cerebrospinal fluid (CSF) of narcolepsy patients.

The team employed several highly sensitive methodologies to provide the data needed, such as:

  • Ex vivo T cell screenings
  • Generation and assessment of single cell clones
  • Deep sequencing of T cell receptors

The results confirmed the existence of circulating autoreactive T cells that target HCRT–producing neurons in narcolepsy patients—the first solid evidence of the autoimmune basis of narcolepsy.

Latorre’s findings also further our understanding of the mechanisms autoreactive T cells use to mount an autoimmune response in narcolepsy, and provide valuable insights for the development of potential treatment targets or intervention/management strategies.

Help us improve your Revvity blog experience!

Feedback

Share this post:

  • Email
  • Facebook
  • Linkedin
  • Twitter

More Disease Research posts

What to consider when choosing a homogenizer for your lab.
Read
What to consider when selecting a centrifuge for your lab.
Read
How extracellular vesicles are reshaping biomarker discovery.
Read

Questions?
We’re here to help.

Contact us
Revvity Logo

Loading...

    ©2025 Revvity - All rights reserved

    Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.